KKorea Exchange Read More Korean-American Biotech Ingenia Therapeutics Wins KOSDAQ Listing ApprovalMay 22, 2026 Ingenia Therapeutics has received preliminary approval from the Korea Exchange for its KOSDAQ listing, the company said Wednesday.…